Oragenics Enters Into Material Transfer Agreement With Adjuvance Technologies for COVID-19 Vaccine Adjuvant January 7, 2021
FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine October 6, 2020
Oragenics Inc. to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference September 11, 2020
Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine August 20, 2020
